fda update tirzepatide Says Compounded Must Exit the Market Important Notice: Tirzepatide Compounding Update

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) examines key variants like GLP1R rs6923761 and GIPR rs1800437 that influence your response to tirzepatide and other peptide therapies

doi: 10.1016/j.jocn.2020.09.054

The semaglutide dosage for diabetes typically starts at 0.25 mg weekly and increases over time

Injections are administered subcutaneously, typically in abdominal fat or other convenient sites

PlexusDx providers can customize your titration pace based on your individual tolerance and clinical goals

16 This study is similar to the trials conducted in adolescents, featuring the same 3.0 mg daily subcutaneous dosage in addition to the lifestyle modifications compared with placebo for 56 weeks, followed by a 26-week follow-up period